A Search Service for Abbreviation / Long Form

■ Abbreviation / Long Form : ZDV / zidovudine

[Related PubMed/MEDLINE]
Total Number of Papers: 755
[Display Entries]
100 entries :
     (Publication year, Descending)
100 entries :
     (Publication year, Ascending)
>> all entries
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation:   ZDV  (>> Co-occurring Abbreviation)
Long Form:   zidovudine
 Abbreviation Variation
 Long Form Variation
 Pair(Abbreviation/Long Form) Variation
No. Year Title Co-occurring Abbreviation
2020 Adverse perinatal outcomes associated with antiretroviral therapy regimens: systematic review and network meta-analysis. ART, LBW, NND, PTB, RCTs, SGA, sPTB, VLBW, VPTB
2020 Assessment of lamivudine, zidovudine, lopinavir, and ritonavir plasma levels in HIV-positive pregnant women: Drug monitoring application to improve patient safety. cART, HIV, LMV, LPV, MRM, PIs, RTV, TDM
2020 Colorimetric Sensor Based on beta-Cyclodextrin-Functionalized Silver Nanoparticles for Zidovudine Sensitive Determination. AgNPs, beta-CD, IR, TEM, UV-vis, XRD
2020 Early cardiac dysfunction in children and young adults with perinatally acquired HIV. CI, LV
2020 Safety and Efficacy of Starting Antiretroviral Therapy in the First Week of Life. ART, LPVr, NVP
2020 Stability behaviour of antiretroviral drugs and their combinations. 11: Characterization of interaction products of zidovudine and efavirenz, and evaluation of their anti HIV-1 activity, and physiochemical and ADMET properties. EFV, HPLC, LC-HRMS, NMR
2020 Structural dynamics and susceptibility of anti-HIV drugs against HBV reverse transcriptase. ddI, dTTP, HBV, HBV-RT, HIV-RT, NAs
2019 A viral genome wide association study and genotypic resistance testing in patients failing first line antiretroviral therapy in the first large countrywide Ethiopian HIV cohort. ART, HIVDR, ITT, NFLG, NRTI/NNRTI, OT
2019 Association between zidovudine-containing antiretroviral therapy exposure in utero and leukocyte telomere length at birth. ART, HEU
10  2019 Hepatic and renal toxicity and associated factors among HIV-infected children on antiretroviral therapy: a prospective cohort study. AST, BUN, cART, CI, GFR, IQR, NVP
11  2019 Intrinsic Replication Competences of HIV Strains After Zidovudine/Lamivudine/Nevirapine Treatment in the Philippines. NVP
12  2019 Nucleoside reverse transcriptase inhibitor backbones and pregnancy outcomes. ABC, aPRs, ART, NRTI, PTD, SGA
13  2019 Safety of 6-week Neonatal Triple-combination Antiretroviral Postexposure Prophylaxis in High-risk HIV-exposed Infants. NVP, PEP
14  2019 Stability behaviour of antiretroviral drugs and their combinations. 9: Identification of incompatible excipients. ABC, EFV, HPLC, LC-HRMS, NMR, NVP, TDF
15  2018 Anemia among HIV Infected Individuals Taking ART with and without Zidovudine at Addis Ababa, Ethiopia. ART
16  2018 Higher Transplacental Pathogen-Specific Antibody Transfer Among Pregnant Women Randomized to Triple Antiretroviral Treatment Versus Short Course Zidovudine. ART
17  2018 In-utero exposure to antiretrovirals and neurodevelopment among HIV-exposed-uninfected children in Botswana. ART, Bayley-III, DMC, HEU
18  2018 Inhibition of UGT2B7 Enzyme Activity in Human and Rat Liver Microsomes by Herbal Constituents. DMEs, HLM, RLM, UGTs
19  2018 Paediatric HIV-1 infection: updated strategies of prevention mother-to-child transmission. CNP, PMTCT
20  2018 Preterm delivery and small-for-gestation outcomes in HIV-infected pregnant women on antiretroviral therapy in rural South Africa: Results from a cohort study, 2010-2015. AOR, ART, EFV, NVP, PTD, SGA, TDF
21  2018 Similar HIV protection from four weeks of zidovudine versus nevirapine prophylaxis among formula-fed infants in Botswana. DAIDS, MTCT, NVP
22  2018 Targeted HIV testing at birth supported by low and predictable mother-to-child transmission risk in Botswana. EIT, MTCT
23  2018 Zidovudine-Based Treatments Inhibit the Glycosylation of ADAM17 and Reduce CD163 Shedding From Monocytes. TDF
24  2017 Anemia among adult HIV patients in Ethiopia: a hospital-based cross-sectional study. AOR, AOR, ART, TB
25  2017 Efficacy and Tolerability of Tenofovir Disoproxil Fumarate Based Regimen as Compared to Zidovudine Based Regimens: A Systematic Review and Meta-Analysis. CI, EFV, HIV, JBI-MAStARI, RNA, RR
26  2017 Incidence of Severe Neutropenia in HIV-Infected People Starting Antiretroviral Therapy in West Africa. aHR, ANC, ART, CI, IeDEA
27  2017 Persistence of Macrocytosis after Discontinuation of Zidovudine in HIV-Infected Patients. MCV
28  2017 Possible Drug-Herb Interaction between Herbal Supplement Containing Horsetail ( Equisetum arvense) and Antiretroviral Drugs. EFV
29  2017 Safety of zidovudine/lamivudine scored tablets in children with HIV infection in Europe and Thailand. AEs, AST, DAIDS, EPPICC, PY, WBC
30  2017 Virological efficacy of 24-week fozivudine-based regimen in ART-naive patients from Tanzania and Cote d'Ivoire. FZD, OD
31  2016 Association between in utero zidovudine exposure and nondefect adverse birth outcomes: analysis of prospectively collected data from the Antiretroviral Pregnancy Registry. ARV, LBW
32  2016 Contribution of different antiretroviral regimens containing zidovudine, lamivudine and ritonavir-boosted lopinavir on HIV viral load reduction during pregnancy. ARV, VL
33  2016 Effectiveness of community-based support for pregnant women living with HIV: a cohort study in South Africa. aHR, aRR, ART, CBS, SSA
34  2016 Efficacy and safety of antiretroviral regimens including raltegravir to treat HIV-infected patients with hemophilia. ART, EFV, NNRTIs, NRTIs
35  2016 Exposure to zidovudine adversely affects mitochondrial turnover in primary T cells. ART, mtROS
36  2016 Foscarnet, zidovudine and dolutegravir combination efficacy and tolerability for late stage HIV salvage therapy: A case-series experience. cART, DTG, OBT, pVL
37  2016 In-utero triple antiretroviral exposure associated with decreased growth among HIV-exposed uninfected infants in Botswana. ---
38  2016 Lamivudine-Induced Skin Rash Remains an Underdiagnosed Entity in HIV: A Case Series from a Single Center. ABC, ART, EFV
39  2016 Lipid Profile in HIV-Infected Patients Using First-Line Antiretroviral Drugs. ARV, CTC, EFV, NVP, TGs
40  2016 Reassuring Birth Outcomes With Tenofovir/Emtricitabine/Efavirenz Used for Prevention of Mother-to-Child Transmission of HIV in Botswana. ART, GA, PMTCT, PTD, SB, SGA
41  2016 Safety of combination antiretroviral prophylaxis in high-risk HIV-exposed newborns: a retrospective review of the Canadian experience. cART, PEP
42  2016 Safety of zidovudine dose reduction in treatment-naive HIV infected patients. A randomized controlled study (MiniZID). ---
43  2015 A randomized, open-label study of the safety and efficacy of switching stavudine or zidovudine to tenofovir disoproxil fumarate in HIV-1-infected children with virologic suppression. TDF
44  2015 Choice of antiretroviral drugs for postexposure prophylaxis for adults and adolescents: a systematic review. CI, PEP
45  2015 Choice of antiretroviral drugs for postexposure prophylaxis for children: a systematic review. ABC, CI, NVP, PEP
46  2015 Development of Severe Anemia and Changes in Hemoglobin in a Cohort of HIV-Infected Ugandan Adults Receiving Zidovudine-, Stavudine-, and Tenofovir-Containing Antiretroviral Regimens. ART, Hb
47  2015 Distal leg epidermal nerve fiber density as a surrogate marker of HIV-associated sensory neuropathy risk: risk factors and change following initial antiretroviral therapy. ART, CI, ENFD, SN
48  2015 In utero exposure to zidovudine and heart anomalies in the ANRS French perinatal cohort and the nested PRIMEVA randomized trial. ARV, CHDs, HIV
49  2015 Long-term follow up of HIV-1-infected Korean haemophiliacs, after infection from a common source of virus. HAART, HLA, HPs, KRG
50  2015 Lopinavir/ritonavir plus lamivudine and abacavir or zidovudine dose ratios for paediatric fixed-dose combinations. ABC, FDC
51  2015 Low Third-Trimester Serum Levels of Lamivudine/Zidovudine and Lopinavir/Ritonavir in an HIV-Infected Pregnant Woman with Gastric Bypass. LPV, RTV
52  2015 Patterns and Predictors of First-Line Antiretroviral Therapy Modification in HIV-1-Infected Adults in a Large Urban Outpatient Cohort in Nigeria. AOR, ART, CI, EFV, NVP
53  2015 Pharmacokinetic Modeling of Lamivudine and Zidovudine Triphosphates Predicts Differential Pharmacokinetics in Seminal Mononuclear Cells and Peripheral Blood Mononuclear Cells. BP, PBMCs, PK, SMCs, SP, ZDV-TP
54  2015 Randomized noninferiority trial of two maternal single-dose nevirapine-sparing regimens to prevent perinatal HIV in Thailand. sdNVP
55  2015 Resistance detected by pyrosequencing following zidovudine monotherapy for prevention of HIV-1 mother-to-child-transmission. ---
56  2015 Serious adverse events are uncommon with combination neonatal antiretroviral prophylaxis: a retrospective case review. AE
57  2015 Switching from zidovudine/lamivudine to tenofovir/emtricitabine improves fat distribution as measured by fat mass ratio. DEXA, FMR
58  2014 A simplified combination antiretroviral therapy regimen enhances adherence, treatment satisfaction and quality of life: results of a randomized clinical trial. QOL
59  2014 Adverse Drug Reactions to Antiretroviral Therapy in HIV-Infected Patients at the Largest Public Hospital in Nicaragua. ADRs, ART, CI
60  2014 Amperometric sensing of anti-HIV drug zidovudine on Ag nanofilm-multiwalled carbon nanotubes modified glassy carbon electrode. CV, EDS, GCE, LSV, MWCNTs, SEM, XRD
61  2014 Anaemia in pregnancy is associated with advanced HIV disease. MTCT
62  2014 Antiretroviral pharmacokinetics in mothers and breastfeeding infants from 6 to 24 weeks post-partum: results of the BAN Study. BAN, BM, IP, LPV/RTV, MP, PK
63  2014 Estimating HIV-1 fitness characteristics from cross-sectional genotype data. HAART, HIV, IDV
64  2014 First-line antiretroviral therapy with nevirapine versus lopinavir-ritonavir based regimens in a resource-limited setting. ART, bPI, DRMs, NNRTI, NRTI, NVP
65  2014 Maternal and fetal zidovudine pharmacokinetics during pregnancy and labour: too high dose infused at labour? ---
66  2014 Preventive antiretroviral therapy in non-thalassemia carrier infants exposed to mother-to-child transmission of HIV decreases cord and after delivery red blood production without altering the development of hemoglobin. ARV, CE, Hb, MTCT, SEA
67  2014 Renal and metabolic toxicities following initiation of HIV-1 treatment regimen in a diverse, multinational setting: a focused safety analysis of ACTG PEARLS (A5175). CrCl, NRTI, OR, RAs, SNADEs, TDF
68  2014 Spectra resolution for simultaneous spectrophotometric determination of lamivudine and zidovudine components in pharmaceutical formulation of human immunodeficiency virus drug based on using continuous wavelet transform and derivative transform techniques. CWT, DS, LMV
69  2014 The connection domain mutation N348I in HIV-1 reverse transcriptase enhances resistance to etravirine and rilpivirine but restricts the emergence of the E138K resistance mutation by diminishing viral replication capacity. E138K, ETR, NRTI, NVP, RPV, RT
70  2014 Transmitted drug resistance in women with intrapartum HIV-1 diagnosis: a pilot epidemiological survey in Buenos Aires, Argentina. HBV, HCV, NVP, RAMs, WHO
71  2013 Anaemia and zidovudine-containing antiretroviral therapy in paediatric antiretroviral programmes in the IeDEA Paediatric West African Database to evaluate AIDS. ART
72  2013 Bone mineral density effects of randomized regimen and nucleoside reverse transcriptase inhibitor selection from ACTG A5142. ARV, DXA, EFV, ITT, NRTIs, TBMD
73  2013 Clinical experience of raltegravir with abacavir/lamivudine or zidovudine/lamivudine in HIV-infected Korean adults. ABC, HIV, RAL
74  2013 Development and validation of an HPLC-UV method for simultaneous determination of zidovudine, lamivudine, and nevirapine in human plasma and its application to pharmacokinetic study in human volunteers. LLOQ, LMV, NVR, QC
75  2013 Drug-resistance development differs between HIV-1-infected patients failing first-line antiretroviral therapy containing nonnucleoside reverse transcriptase inhibitors with and without thymidine analogues. NNRTI, non-TAs, NRTI, RTIs
76  2013 Early outcome of second line antiretroviral therapy in treatment-experienced human immunodeficiency virus positive patients. ADRs, ART, HIV, pVL
77  2013 Early upper digestive tract side effects of zidovudine with tenofovir plus emtricitabine in West African adults with high CD4 counts. ART, CTX, EFV, NNRTIs, SAEs
78  2013 High exposure to zidovudine during the first 2 weeks of life and concentration-toxicity relationships. ---
79  2013 High throughput LC-MS/MS method for simultaneous determination of zidovudine, lamivudine and nevirapine in human plasma. NVP, SPE
80  2013 Impact of baseline HIV-1 RNA levels on initial highly active antiretroviral therapy outcome: a meta-analysis of 12,370 patients in 21 clinical trials*. ABC, CI, NNRTI, NRTI
81  2013 Is intrapartum intravenous zidovudine for prevention of mother-to-child HIV-1 transmission still useful in the combination antiretroviral therapy era? cART, HIV, MTCT
82  2013 Optimizing HIV treatment. ATV
83  2013 Population pharmacokinetics study of recommended zidovudine doses in HIV-1-infected children. b.i.d, FDA, WB, WHO
84  2013 Risk adapted transmission prophylaxis to prevent vertical HIV-1 transmission: effectiveness and safety of an abbreviated regimen of postnatal oral zidovudine. CI, MTCT
85  2013 Short communication: effect of short-course antenatal zidovudine and single-dose nevirapine on the BED capture enzyme immunoassay levels in HIV type 1 subtype C infection. ODn, sdNVP
86  2013 Synthesis, characterization and targeting potential of zidovudine loaded sialic acid conjugated-mannosylated poly(propyleneimine) dendrimers. MPPI, PPI, SMPPI, SPPI
87  2013 The NRTIs lamivudine, stavudine and zidovudine have reduced HIV-1 inhibitory activity in astrocytes. ABC, ARVs, CNS, CSF, EFV, ETR, MDM, Neuro-cART, NRTIs, NVP, PFA, RAL, VSV-G
88  2013 Therapeutic levels of lopinavir in late pregnancy and abacavir passage into breast milk in the Mma Bana Study, Botswana. ABC, LPV, NVP
89  2013 Vitamin D attenuates nucleoside reverse transcriptase inhibitor induced human skeletal muscle mitochondria DNA depletion. ABC, ddI, mtDNA, NRTI
90  2013 Zidovudine impairs immunological recovery on first-line antiretroviral therapy: collaborative analysis of cohort studies in southern Africa. ART, CI
91  2012 Antiretroviral prophylaxis for breastfeeding transmission in Malawi: drug concentrations, virological efficacy and safety. NVP
92  2012 Autophagy inhibition due to thymidine analogues as novel mechanism leading to hepatocyte dysfunction and lipid accumulation. NRTI
93  2012 Biphasic elimination of tenofovir diphosphate and nonlinear pharmacokinetics of zidovudine triphosphate in a microdosing study. PBMCs, PKs, TFV, TFV-DP, ZDV-TP
94  2012 Cost-effectiveness of tenofovir instead of zidovudine for use in first-line antiretroviral therapy in settings without virological monitoring. QALY, WHO
95  2012 Differential in vitro kinetics of drug resistance mutation acquisition in HIV-1 RT of subtypes B and C. ---
96  2012 Effect of HIV-1 infection and sex on the cellular pharmacology of the antiretroviral drugs zidovudine and lamivudine. CI
97  2012 Effectiveness of generic and proprietary first-line anti-retroviral regimens in a primary health care setting in Lusaka, Zambia: a cohort study. aHR, ART, CI
98  2012 Effects of short-course zidovudine on the selection of nevirapine-resistant HIV-1 in women taking single-dose nevirapine. sdNVP
99  2012 Evaluation of different antiretroviral drug protocols on naturally infected feline immunodeficiency virus (FIV) cats in the late phase of the asymptomatic stage of infection. FIV, rHuIFN-alpha, Valp
100  2012 Evaluation of preventive measures for mother-to-child transmission of HIV in Aracaju, State of Sergipe, Brazil. ACTG 076, HIV